Ofatumumab in the treatment of multiple sclerosis – from clinical outcomes to the economic sustainability of treatment
Česká a slovenská neurologie a neurochirurgie · 28.02.2026 · 122 (1)
DOI: 10.48095/cccsnn20269 ↗Kurz gefasst
Fachartikel in der Zeitschrift Česká a slovenská neurologie a neurochirurgie, online erschienen am 28.02.2026. Verfasst von Simona Halúsková und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Halúsková, S., Vališ, M., & Pavelek, Z. (2026). Ofatumumab in the treatment of multiple sclerosis – from clinical outcomes to the economic sustainability of treatment. Česká a slovenská neurologie a neurochirurgie, 122(1). https://doi.org/10.48095/cccsnn20269
Vancouver
Halúsková S, Vališ M, Pavelek Z. Ofatumumab in the treatment of multiple sclerosis – from clinical outcomes to the economic sustainability of treatment. Česká a slovenská neurologie a neurochirurgie. 2026;122(1). doi:10.48095/cccsnn20269
BibTeX
@article{Halskov2026,
author = {Halúsková, Simona and Vališ, Martin and Pavelek, Zbyšek},
title = {Ofatumumab in the treatment of multiple sclerosis – from clinical outcomes to the economic sustainability of treatment},
journal = {Česká a slovenská neurologie a neurochirurgie},
year = {2026},
volume = {122},
number = {1},
doi = {10.48095/cccsnn20269}
}
EUVIMED